{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:06Z","timestamp":1792782966497,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Blodcancerfonden"},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional agreement on medical training and clinical research (ALF)"},{"name":"The Karolinska Institutet Foundations","id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The University of Iceland Research Fund","id":[{"id":"https:\/\/ror.org\/01db6h964","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Icelandic Center for Research (RANNIS)","id":[{"id":"https:\/\/ror.org\/03srneg48","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Landsp\u00edtali University Hospital Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00277-016-2859-8","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:24:10Z","timestamp":1478046250000},"page":"261-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study"],"prefix":"10.1007","volume":"96","author":[{"given":"Ebba K.","family":"Lindqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigr\u00fan H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Hultcrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"key":"2859_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S Swerdlov","year":"2008","unstructured":"Swerdlov S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC, Lyon","edition":"4"},{"key":"2859_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21\u201333","journal-title":"Mayo Clin Proc"},{"key":"2859_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564\u2013569","journal-title":"N Engl J Med"},{"key":"2859_CR4","first-page":"785","volume":"114","author":"CM Vachon","year":"2009","unstructured":"Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV (2009) Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance; Blood. United States 114:785\u2013790","journal-title":"United States"},{"key":"2859_CR5","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","volume":"118","author":"O Landgren","year":"2006","unstructured":"Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR (2006) Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer 118:3095\u20133098","journal-title":"Int J Cancer"},{"key":"2859_CR6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","volume":"114","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH, Wahlin A, Bjorkholm M, Turesson I (2009) Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood 114:791\u2013795","journal-title":"Blood"},{"key":"2859_CR7","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","volume":"125","author":"SY Kristinsson","year":"2009","unstructured":"Kristinsson SY, Bjorkholm M, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2009) Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer 125:2147\u20132150","journal-title":"Int J Cancer"},{"key":"2859_CR8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","volume":"23","author":"O Landgren","year":"2009","unstructured":"Landgren O, Weiss BM (2009) Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis. Leukemia 23:1691\u20131697","journal-title":"Leukemia"},{"key":"2859_CR9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, Fears TR, Hoover RN, Linet MS (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107:904\u2013906","journal-title":"Blood"},{"key":"2859_CR10","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, Rajkumar SV, Alavanja MC (2009) Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood 113:6386\u20136391","journal-title":"Blood"},{"key":"2859_CR11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354:1362\u20131369","journal-title":"N Engl J Med"},{"key":"2859_CR12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamaoncol.2015.2938","volume":"1","author":"O Landgren","year":"2015","unstructured":"Landgren O, Shim YK, Michalek J, Costello R, Burton D, Ketchum N, Calvo KR, Caporaso N, Raveche E, Middleton D, Marti G, Vogt RF Jr (2015) Agent orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand Veteran Cohort Study. JAMA Oncol 1:1061\u20131068","journal-title":"JAMA Oncol"},{"key":"2859_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ejhg.2008.163","volume":"17","author":"P Forabosco","year":"2009","unstructured":"Forabosco P, Bouzigon E, Ng MY, Hermanowski J, Fisher SA, Criswell LA, Lewis CM (2009) Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 17:236\u2013243","journal-title":"Eur J Hum Genet"},{"key":"2859_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrg2489","volume":"10","author":"A Zhernakova","year":"2009","unstructured":"Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10:43\u201355","journal-title":"Nat Rev Genet"},{"key":"2859_CR15","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","volume":"124","author":"LR Goldin","year":"2009","unstructured":"Goldin LR, Landgren O (2009) Autoimmunity and lymphomagenesis. Int J Cancer 124:1497\u20131502","journal-title":"Int J Cancer"},{"key":"2859_CR16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cncr.25524","volume":"117","author":"AM Landgren","year":"2011","unstructured":"Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM (2011) Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 117:1163\u20131171","journal-title":"Cancer"},{"key":"2859_CR17","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdr590","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Ann Oncol 23:2179\u20132184","journal-title":"Ann Oncol"},{"key":"2859_CR18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1183\/09031936.00222911","volume":"40","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J 40:1489\u20131495","journal-title":"Eur Respir J"},{"key":"2859_CR19","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1002\/ijc.27376","volume":"131","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K (2012) Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease. Int J Cancer 131:E326\u2013E328","journal-title":"Int J Cancer"},{"key":"2859_CR20","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","volume":"118","author":"EK Lindqvist","year":"2011","unstructured":"Lindqvist EK, Goldin LR, Landgren O, Blimark C, Mellqvist UH, Turesson I, Wahlin A, Bjorkholm M, Kristinsson SY (2011) Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood 118:6284\u20136291","journal-title":"Blood"},{"key":"2859_CR21","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","volume":"111","author":"LM Brown","year":"2008","unstructured":"Brown LM, Gridley G, Check D, Landgren O (2008) Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 111:3388\u20133394","journal-title":"Blood"},{"key":"2859_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-5-59","volume":"5","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Liu X, Forsti A, Ji J, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol 5:59","journal-title":"J Hematol Oncol"},{"key":"2859_CR23","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","volume":"90","author":"SJ Walsh","year":"2000","unstructured":"Walsh SJ, Rau LM (2000) Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 90:1463\u20131466","journal-title":"Am J Public Health"},{"key":"2859_CR24","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2105\/AJPH.2009.180273","volume":"100","author":"SL Thomas","year":"2010","unstructured":"Thomas SL, Griffiths C, Smeeth L, Rooney C, Hall AJ (2010) Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Public Health 100:2279\u20132287","journal-title":"Am J Public Health"},{"key":"2859_CR25","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1200\/JCO.2010.29.2243","volume":"28","author":"O Landgren","year":"2010","unstructured":"Landgren O, Pfeiffer RM, Kristinsson SY, Bjorkholm M (2010) Survival patterns in patients with Hodgkin\u2019s lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease. J Clin Oncol 28:5081\u20135087","journal-title":"J Clin Oncol"},{"key":"2859_CR26","unstructured":"Swedish National Board of Health and Welfare. Svenska cancerregistret. Socialstyrelsen, Stockholm, Sweden"},{"key":"2859_CR27","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.22912","volume":"121","author":"I Turesson","year":"2007","unstructured":"Turesson I, Linet MS, Bjorkholm M, Kristinsson SY, Goldin LR, Caporaso NE, Landgren O (2007) Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer 121:2260\u20132266","journal-title":"Int J Cancer"},{"key":"2859_CR28","first-page":"598","volume":"91","author":"A Nilsson","year":"1994","unstructured":"Nilsson A, Spetz C, Carsjo K, Nightingale R, Smedby B (1994) Slutenv\u00e5rdsregistrets tillf\u00f6rlitlighet. Lakartidningen 91:598\u2013605","journal-title":"Lakartidningen"},{"key":"2859_CR29","unstructured":"Swedish National Board of Health and Welfare. Patientregistret. Socialstyrelsen, Stockholm, Sweden"},{"key":"2859_CR30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnci\/djq043","volume":"102","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Koshiol J, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O (2010) Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst 102:557\u2013567","journal-title":"J Natl Cancer Inst"},{"key":"2859_CR31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","volume":"85","author":"SV Rajkumar","year":"2010","unstructured":"Rajkumar SV, Kyle RA, Buadi FK (2010) Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc 85:945\u2013948","journal-title":"Mayo Clin Proc"},{"key":"2859_CR32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4065\/mcp.2009.0426","volume":"85","author":"I Turesson","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O (2010) Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc 85:225\u2013230","journal-title":"Mayo Clin Proc"},{"key":"2859_CR33","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","volume":"118","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Blade J, Mateos MV, Rosinol L, Boccadoro M, Cavo M, Lokhorst H, Zweegman S, Terpos E, Davies F, Driessen C, Gimsing P, Gramatzki M, Hajek R, Johnsen HE, Leal Da Costa F, Sezer O, Spencer A, Beksac M, Morgan G, Einsele H, San Miguel JF, Sonneveld P (2011) Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood 118:4519\u20134529","journal-title":"Blood"},{"issue":"5","key":"2859_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clml.2013.03.013","volume":"3","author":"M Kleber","year":"2013","unstructured":"Kleber M, Ihorst G, Gross B, Koch B, Reinhardt H, Wasch R, Engelhardt M (2013) Validation of the Freiburg comorbidity index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome. Clin Lymphoma Myeloma Leuk 3(5):541\u2013551","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2859_CR35","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/bcj.2011.34","volume":"1","author":"M Kleber","year":"2011","unstructured":"Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, Engelhardt M (2011) Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J 1:e35","journal-title":"Blood Cancer J"},{"key":"2859_CR36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clml.2012.06.008","volume":"12","author":"M Offidani","year":"2012","unstructured":"Offidani M, Corvatta L, Polloni C, Centurioni R, Visani G, Brunori M, Gentili S, Catarini M, Samori A, Blasi N, Alesiani F, Caraffa P, Burattini M, Galieni P, Fraticelli P, Ferranti M, Giuliodori L, Leoni P (2012) Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. Clin Lymphoma Myeloma Leuk 12:423\u2013432","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2859_CR37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1600-0609.2009.01318.x","volume":"83","author":"M Kleber","year":"2009","unstructured":"Kleber M, Ihorst G, Deschler B, Jakob C, Liebisch P, Koch B, Sezer O, Engelhardt M (2009) Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients. Eur J Haematol 83:519\u2013527","journal-title":"Eur J Haematol"},{"key":"2859_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/leu.2009.1","volume":"23","author":"L Farina","year":"2009","unstructured":"Farina L, Bruno B, Patriarca F, Spina F, Sorasio R, Morelli M, Fanin R, Boccadoro M, Corradini P (2009) The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia 23:1131\u20131138","journal-title":"Leukemia"},{"key":"2859_CR39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/leu.2012.271","volume":"27","author":"P Falco","year":"2013","unstructured":"Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, Grasso M, Siez ML, De Paoli L, Oliva S, Molica S, Mina R, Gay F, Benevolo G, Musto P, Omede P, Freilone R, Bringhen S, Carella AM, Gaidano G, Boccadoro M, Palumbo A (2013) Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients. Leukemia 27:695\u2013701","journal-title":"Leukemia"},{"key":"2859_CR40","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25:1993\u20131999","journal-title":"J Clin Oncol"},{"key":"2859_CR41","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.2009.25.4177","volume":"28","author":"I Turesson","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O (2010) Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol 28:830\u2013834","journal-title":"J Clin Oncol"},{"issue":"5","key":"2859_CR42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2013","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV (2013) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28(5):1122\u20131128","journal-title":"Leukemia"},{"issue":"6","key":"2859_CR43","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/leu.2014.23","volume":"28","author":"SY Kristinsson","year":"2014","unstructured":"Kristinsson SY, Anderson WF, Landgren O (2014) Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia 28(6):1346","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2859-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:35:29Z","timestamp":1498343729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2859"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2859-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}